Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells

BACKGROUND: The metabolic enzyme carbonic anhydrase 12 (CA12/CAXII) emerges as a promising cancer therapeutic target with drug development projects underway. Previous reports proposed the relevance of CA12 in the context of glioma but are limited in patient data quantity, ignore ethnic diversity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guanzhang, Chen, Ting-Wei, Nickel, Ann-Christin, Muhammad, Sajjad, Steiger, Hans-Jakob, Tzaridis, Theophilos, Hänggi, Daniel, Zeidler, Reinhard, Zhang, Wei, Kahlert, Ulf Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939492/
https://www.ncbi.nlm.nih.gov/pubmed/33692626
http://dx.doi.org/10.2147/OTT.S300623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939492/
https://www.ncbi.nlm.nih.gov/pubmed/33692626
http://dx.doi.org/10.2147/OTT.S300623

Ejemplares similares